John K. Walker

1.9k total citations
49 papers, 1.1k citations indexed

About

John K. Walker is a scholar working on Molecular Biology, Organic Chemistry and Molecular Medicine. According to data from OpenAlex, John K. Walker has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Organic Chemistry and 10 papers in Molecular Medicine. Recurrent topics in John K. Walker's work include Antibiotic Resistance in Bacteria (10 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers) and Synthesis and biological activity (5 papers). John K. Walker is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers) and Synthesis and biological activity (5 papers). John K. Walker collaborates with scholars based in United States, Italy and United Kingdom. John K. Walker's co-authors include Helen I. Zgurskaya, Jerry M. Parks, Valentin V. Rybenkov, Thomas P. Burris, Arindam Chatterjee, Bahaa Elgendy, Jeremy C. Smith, Melissa Kazantzis, David Wolloscheck and Theodore M. Kamenecka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Accounts of Chemical Research.

In The Last Decade

John K. Walker

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John K. Walker United States 20 483 216 193 123 114 49 1.1k
Rana Anjum India 12 1.0k 2.1× 296 1.4× 93 0.5× 179 1.5× 98 0.9× 20 1.4k
Ryan E. Pavlovicz United States 15 766 1.6× 82 0.4× 90 0.5× 69 0.6× 115 1.0× 24 1.3k
Naoki Sakura Japan 17 483 1.0× 148 0.7× 97 0.5× 138 1.1× 45 0.4× 75 990
Nadezhda German United States 19 441 0.9× 134 0.6× 101 0.5× 82 0.7× 63 0.6× 42 896
Mohammad Altaf India 17 1.8k 3.7× 150 0.7× 92 0.5× 169 1.4× 147 1.3× 30 2.2k
Daren Stephens United States 18 787 1.6× 74 0.3× 139 0.7× 46 0.4× 55 0.5× 22 1.2k
Kazumasa Yokoyama Japan 21 490 1.0× 60 0.3× 91 0.5× 56 0.5× 77 0.7× 53 1.2k
Byung Woo Han South Korea 24 1.2k 2.4× 56 0.3× 271 1.4× 215 1.7× 118 1.0× 99 1.8k
Ying‐Duo Gao United States 20 779 1.6× 158 0.7× 133 0.7× 194 1.6× 17 0.1× 27 1.3k
Michael J. Stocks United Kingdom 23 800 1.7× 142 0.7× 698 3.6× 182 1.5× 32 0.3× 81 1.6k

Countries citing papers authored by John K. Walker

Since Specialization
Citations

This map shows the geographic impact of John K. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John K. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John K. Walker more than expected).

Fields of papers citing papers by John K. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John K. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John K. Walker. The network helps show where John K. Walker may publish in the future.

Co-authorship network of co-authors of John K. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of John K. Walker. A scholar is included among the top collaborators of John K. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John K. Walker. John K. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saral, Ayşegül, Inga V. Leus, Mithila Farjana, et al.. (2025). Mutations in the proximal binding site and F-loop of AdeJ confer resistance to efflux pump inhibitors. Antimicrobial Agents and Chemotherapy. 69(8). e0009025–e0009025.
2.
Manrique, Pedro D., Inga V. Leus, César A. López, et al.. (2024). Predicting permeation of compounds across the outer membrane of P. aeruginosa using molecular descriptors. Communications Chemistry. 7(1). 84–84. 4 indexed citations
3.
Saral, Ayşegül, et al.. (2024). AdeIJK Pump-Specific Inhibitors Effective against Multidrug Resistant Acinetobacter baumannii. ACS Infectious Diseases. 10(6). 2239–2249. 4 indexed citations
4.
Hayes, Matthew, Danesh H. Sopariwala, Ryan L. Sanders, et al.. (2024). The Estrogen Receptor-Related Orphan Receptors Regulate Autophagy through TFEB. Molecular Pharmacology. 106(4). 164–172. 2 indexed citations
5.
Sitaula, Sadichha, Cyrielle Billon, Arindam Chatterjee, et al.. (2023). Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915. European Journal of Medicinal Chemistry. 258. 115582–115582. 4 indexed citations
6.
Cao, Feng, et al.. (2023). Identification and structure–activity relationships for a series of N, N-disubstituted 2-aminobenzothiazoles as potent inhibitors of S. aureus. Bioorganic & Medicinal Chemistry Letters. 89. 129301–129301. 7 indexed citations
7.
Herdendorf, Timothy J., Huiquan Duan, Sanjay Khandelwal, et al.. (2023). Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl)Pyridine-3-Carboximidamide and Chemical Analogs. The Journal of Immunology. 212(4). 689–701. 4 indexed citations
9.
Billon, Cyrielle, Arindam Chatterjee, Andrew A. Butler, et al.. (2023). A Synthetic ERR Agonist Alleviates Metabolic Syndrome. Journal of Pharmacology and Experimental Therapeutics. 388(2). 232–240. 15 indexed citations
10.
Moniruzzaman, Mohammad, Giuliano Malloci, Connor J. Cooper, et al.. (2021). Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides. ACS Infectious Diseases. 7(9). 2650–2665. 16 indexed citations
11.
Sather, D. Noah, et al.. (2021). A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2. Frontiers in Pharmacology. 12. 685308–685308. 13 indexed citations
12.
Moniruzzaman, Mohammad, Connor J. Cooper, John K. Walker, et al.. (2020). Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(6). 129546–129546. 34 indexed citations
13.
Giancotti, Luigino Antonio, Zhoumou Chen, Bonne M. Thompson, et al.. (2020). GPR183-Oxysterol Axis in Spinal Cord Contributes to Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 375(2). 367–375. 21 indexed citations
14.
Flaveny, Colin A., Kristine Griffett, Bahaa Elgendy, et al.. (2015). Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis. Cancer Cell. 28(1). 42–56. 160 indexed citations
15.
Hughes, Robert, Todd M. Maddux, D. Joseph Rogier, et al.. (2011). Investigation of the pyrazinones as PDE5 inhibitors: Evaluation of regioisomeric projections into the solvent region. Bioorganic & Medicinal Chemistry Letters. 21(21). 6348–6352. 12 indexed citations
16.
Li, Xing, Balekudru Devadas, Rajesh Devraj, et al.. (2011). Discovery and Characterization of Atropisomer PH‐797804, a p38 MAP Kinase Inhibitor, as a Clinical Drug Candidate. ChemMedChem. 7(2). 273–280. 32 indexed citations
17.
Tollefson, Michael B., E. Jon Jacobsen, Robert Hughes, et al.. (2010). 1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(10). 3120–3124. 21 indexed citations
18.
Hepperle, Michael, et al.. (2010). Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 20(10). 3146–3149. 7 indexed citations
19.
Bláha, M., et al.. (2001). Ultrastructural and Histological Effects of Exposure to CEES or Heat in a Human Epidermal Model. PubMed. 14(1). 15–23. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026